USPTO serial 97761638
INSTANT URGENT CARE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BRYANT, ALEXANDRIA N
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INSTANT URGENT CARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas Y. Yee
Thomas Y. Yee Perkins Coie LLPP.O. Box 2608Seattle, WA 98111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Rapid test kits for scientific and research use comprised of chemical reagents, solvents, swabs, vials, and containers for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; media for cultures for scientific and research use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants | ACTIVE | — |
| 005 | Diagnostic preparations for medical purposes; medical diagnostic rapid test kits comprised of chemical reagents, solvents, swabs, vials, and containers for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; diagnostic media for cultures for use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; rapid test kits for medical purposes comprised of chemical reagents, solvents, swabs, vials and containers for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants | ACTIVE | — |
| 009 | Downloadable software and downloadable mobile applications for use in detecting, screening, and monitoring the presence of diseases; downloadable software and downloadable mobile applications for use in providing medical and health related education and training; downloadable software and downloadable mobile applications for use with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis | ACTIVE | — |
| 036 | Financial administration of health reimbursement arrangements and programs; Reimbursement payment processing in the field of insurance claims; Providing healthcare administration, namely, providing insurance verification and reimbursement payment processing services in the field of pharmaceutical and health insurance claims | ACTIVE | — |
| 038 | Audio teleconferencing; Instant messaging services; Network conferencing services; Teleconferencing services; Video conferencing services; Video teleconferencing | ACTIVE | — |
| 039 | Delivery of medicine, prescription drugs, and therapeutic products | ACTIVE | — |
| 042 | Providing on-line, non-downloadable internet-based software for use in detecting, screening and monitoring the presence of diseases; providing on-line, non-downloadable cloud-based software for use in detecting, screening and monitoring the presence of diseases; software as a service (SAAS) services featuring software for use in detecting, screening and monitoring the presence of diseases; platform as a service (PAAS) featuring software for detecting, screening, and monitoring the presence of diseases; providing on-line, non-downloadable internet-based software for use in conducting medical and health related education and training; providing on-line, non-downloadable cloud-based software for use in conducting medical and health related education and training; software as a service (SAAS) services featuring software for use in conducting medical and health related education and training; platform as a service (PAAS) featuring software for use in conducting medical and health related education and training; providing on-line, non-downloadable internet-based software for data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; providing on-line, non-downloadable cloud-based software with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; software as a service (SAAS) services featuring software for data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; platform as a service (PAAS) featuring software for data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; providing temporary use of on-line non-downloadable software applications with detecting, screening, and monitoring the presence of diseases; providing temporary use of on-line non-downloadable software applications for use in conducting medical and health related education and training; providing temporary use of on-line non-downloadable software applications with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for live digital communications, namely, live video and audio conferencing with multiple simultaneous users, teleconferencing, and network conferencing; software as a service (SAAS) services featuring software for providing an online platform to enable workflow management of a proctored examination; software as a service (SAAS) services featuring software for providing a non-downloadable online platform to enable video conferencing connectivity between proctors and users to conduct a proctored test; platform as a service (PAAS) featuring computer software platforms for proctoring of exams; platform as a service (PAAS) featuring computer software platforms for providing online identity verification services and for creating identity verification reports; platform as a service (PAAS) featuring computer software platforms for providing process verification services for businesses and for creating process verification reports; cloud based software as a service (SAAS) services featuring AI-enabled software for proctoring to ensure integrity of remote assessments with real-time image, audio, and video proctoring, assessing functional, programming, technical and communication skills in real-time with video interviews, preventing cheating using AI, and conducting video interviews; software as a service (SAAS) services featuring software for secure exam proctoring and content protection, identification verification, and data analytics associated therewith; software as a service (SAAS) services featuring software for providing proctored examination testing, examination monitoring, and for reporting examination results to government agencies, insurers, employers, companies, and users; providing temporary use of on-line non-downloadable cloud-based computer software for autonomous online proctoring and identity verification; providing temporary use of online non-downloadable software for enabling video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables users to order diagnostic tests, to take diagnostic tests online with the guidance of a proctor, to view and access test results, and to order pharmaceuticals and prescriptions; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables AI-based guidance through self-administered diagnostic tests; software as a service (SAAS) services featuring software for providing an online platform that enables users to access digital health results; identity verification services, namely, providing electronic verification of identity of user using single sign-on technology to confirm on-line test results and generating electronic permission codes which then allow users to access said digital content;providing user authentication of personal identifying information via secure storage and transmission of supporting evidence via the internet using single sign-on technology for online software applications; providing document verification services, namely, providing remote identity document scanning being electronic scanning of personally identifying photographic images, photo scanning, digitization of documents, data extraction being data encryption, data decryption for authentication and verification purposes; providing prescription drug release user authentication services via secure storage and transmission of supporting evidence via the internet for online software applications using single sign-on technology; providing user authentication services using single sign on technology for using software technology for personal identity verification for telemedicine | ACTIVE | — |
| 044 | Telemedicine services, namely, providing remote proctoring of diagnostic tests; providing digital educational health information relating to disease | ACTIVE | — |
| 045 | Prescription drug release verification services being verification of personal identity as part of personal background analysis of courier service providers; verification of personal identity as part of personal background analysis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EMED, LLC
- Other trademarks owned by EMED, LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 036
- Other trademarks in Class 038
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named INSTANT URGENT CARE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 29, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 29, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 26, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 31, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 31, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 11, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 23, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 23, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 23, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 23, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 23, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 6, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 6, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 6, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 10, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 9, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 23, 2023 | NWAP | NEW APPLICATION ENTERED | — |